Watson Rebecca’s Pfizer PFE Stock Holding History

Watson Rebecca’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$501K	Buy	14,398 +6,850	+91%	+$240K	0.3%	40
2020 Q2	$234K	Hold	7,548	–	–	0.14%	71
2020 Q1	$257K	Sell	7,548 -1,091	-13%	-$37.2K	0.18%	63
2019 Q4	$321K	Buy	+8,639	New	+$308K	0.19%	63

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Watson Rebecca's PFE Position: Q3 2020 in Review

Watson Rebecca increased its Pfizer (PFE) stake by 91% in Q3 2020, buying an estimated $240K and bringing the position to 14,398 shares worth $501K. The position accounts for 0.3% of the portfolio, ranked #40.

Watson Rebecca first reported a position in PFE in Q4 2019 and has held it in 4 quarters since. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Watson Rebecca held 14,398 shares of Pfizer worth $501K as of Q3 2020.
Watson Rebecca bought 6,850 Pfizer shares in Q3 2020, an estimated $240K.
Pfizer made up 0.3% of Watson Rebecca's portfolio in Q3 2020, its #40 holding.
Watson Rebecca first reported a position in Pfizer in Q4 2019 and has held it in 4 quarters since.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.